Physician profile
Alessandro Boschi
NPI 1104904671
$2,127.13
in general payments reported to CMS, 2019-2025
17 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $96.99 · 2021: $604 · 2022: $171 · 2023: $379 · 2024: $324 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $641.12 | 2019-2025 | Gardasil 9, Gardasil |
| Abbvie INC. | $387.25 | 2021-2024 | |
| Exact Sciences Corporation | $200.96 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $153.24 | 2022-2025 | Veozah |
| Pfizer INC. | $124.56 | 2021-2024 | |
| Roche Diagnostics Corporation | $92.15 | 2019 | |
| Lupin INC. | $86.45 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $84.72 | 2019-2020 | |
| Myovant Sciences INC. | $77.56 | 2021-2022 | |
| Minerva Surgical, INC | $67.88 | 2020-2023 | |
| Axonics, INC. | $56.38 | 2023 | Axonics, Bulkamid |
| Mayne Pharma Commercial LLC | $43.30 | 2025 | |
| Allergan, INC. | $28.74 | 2019 | |
| Exeltis, USA INC. | $24.22 | 2025 | Slynd |
| Sumitomo Pharma America, INC. | $22.32 | 2025 | Gemtesa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $18.99 | 2025 | Intrarosa, Femlyv |
| Hologic Sales and Service, LLC | $17.29 | 2023 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alessandro Boschi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.